In its essence, post-trial obligations describe a duty by research sponsors to provide a successfully tested drug to research participants who took part in the relevant clinical trials after the trial has been concluded. In some instances, this duty is extended beyond the research participants. This article is divided into three main parts. The first part outlines the legal basis for post-trial obligations by looking at international guidelines, including those issued by the World Medical Association. National legislation is exemplified through resolutions and guidelines issued by Brazil and South Africa respectively. The second part analyses the ethical foundation for post-trial obligations, in particular the attempt to minimize exploitati...
The problem of transitioning research participants to the appropriate health care when the study fin...
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and ...
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and ...
This paper discusses the post-trial access to drugs for patients who participated in clinical trials...
This paper discusses the post-trial access to drugs for patients who participated in clinical trials...
This paper discusses the post-trial access to drugs for patients who participated in clinical trials...
The article explores the modern condition of the legal regulation of post-trial access to investigat...
Busca-se demonstrar nesta tese que o instituto de Direito Internacional Privado das normas de aplica...
Objectives To analyse the perspective of clinical research stakeholders concerning post-trial access...
Objectives To analyse the perspective of clinical research stakeholders concerning post-trial access...
Objectives To analyse the perspective of clinical research stakeholders concerning post-trial access...
This paper describes some ethical problems derived from multi center studies in developing countries...
ResumoA continuidade do tratamento com os medicamentos investigacionais após a conclusão de uma pesq...
The performance of Clinical Trials can give rise to ethical problems especially between the research...
SummaryThe post-trial access to investigational drugs has been the object of discussion since the la...
The problem of transitioning research participants to the appropriate health care when the study fin...
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and ...
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and ...
This paper discusses the post-trial access to drugs for patients who participated in clinical trials...
This paper discusses the post-trial access to drugs for patients who participated in clinical trials...
This paper discusses the post-trial access to drugs for patients who participated in clinical trials...
The article explores the modern condition of the legal regulation of post-trial access to investigat...
Busca-se demonstrar nesta tese que o instituto de Direito Internacional Privado das normas de aplica...
Objectives To analyse the perspective of clinical research stakeholders concerning post-trial access...
Objectives To analyse the perspective of clinical research stakeholders concerning post-trial access...
Objectives To analyse the perspective of clinical research stakeholders concerning post-trial access...
This paper describes some ethical problems derived from multi center studies in developing countries...
ResumoA continuidade do tratamento com os medicamentos investigacionais após a conclusão de uma pesq...
The performance of Clinical Trials can give rise to ethical problems especially between the research...
SummaryThe post-trial access to investigational drugs has been the object of discussion since the la...
The problem of transitioning research participants to the appropriate health care when the study fin...
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and ...
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and ...